+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Cardiopulmonary Autotransfusion Systems Market by Product, Application, End User - Global Forecast to 2030- Product Image
Cardiopulmonary Autotransfusion Systems Market by Product, Application, End User - Global Forecast to 2030- Product Image
Sale

Cardiopulmonary Autotransfusion Systems Market by Product, Application, End User - Global Forecast to 2030

  • PDF Icon

    Report

  • 188 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 6010717
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Cardiopulmonary Autotransfusion Systems Market grew from USD 581.63 million in 2024 to USD 599.00 million in 2025. It is expected to continue growing at a CAGR of 2.87%, reaching USD 689.52 million by 2030.

Revolutionizing Patient Care through Autotransfusion

Cardiopulmonary autotransfusion systems represent a pivotal advancement in intraoperative blood management, enabling clinicians to collect, process, and reinfuse a patient’s own blood during surgery. By minimizing the reliance on allogeneic transfusions, these systems lower the risk of transfusion-related complications, reduce healthcare costs, and support enhanced patient recovery. As surgical disciplines increasingly emphasize patient safety and cost efficiency, autotransfusion technologies have emerged as indispensable tools in complex operative settings.

This executive summary synthesizes the latest industry developments, market dynamics, and strategic considerations pertinent to cardiopulmonary autotransfusion systems. It is designed to equip healthcare providers, equipment manufacturers, investors, and policymakers with a concise yet comprehensive overview of the forces shaping this rapidly evolving market. Through an integrated narrative of technological trends, regulatory shifts, and competitive movements, the following sections provide a solid foundation for informed decision-making and strategic planning.

Emerging Forces Redefining Autotransfusion Dynamics

Over the past few years, the landscape of autotransfusion has undergone transformative shifts driven by a confluence of technological innovation, changing surgical paradigms, and heightened regulatory scrutiny. Advanced filtration and washing technologies are raising the bar in blood salvage efficiency, offering improved removal of microaggregates and inflammatory mediators. Meanwhile, the miniaturization of centrifugal components and integration of closed-loop controls are facilitating seamless operation in both elective and trauma situations.

Concurrently, the move toward minimally invasive and robotic-assisted procedures has spurred demand for compact, portable autotransfusion units that can be deployed in hybrid operating rooms and emergency field settings. Digital connectivity and real-time data analytics are also redefining clinical workflows, enabling care teams to monitor and optimize autotransfusion performance on the fly. Environmental sustainability has emerged as another key driver, with manufacturers exploring reusable components and eco-friendly disposables to align with institutional green initiatives.

Assessing the Ripple Effects of New US Tariff Policies

In 2025, newly implemented tariffs on imported medical devices and related consumables have imparted a ripple effect across the autotransfusion market. Producers of filtration cartridges and washing kits have faced increased input costs, compelling a reassessment of their global sourcing strategies. Some manufacturers have responded by shifting production to tariff-exempt regions or absorbing marginal cost increases to maintain competitive pricing.

The systems segment has similarly felt the impact, with centrifugal autotransfusion units encountering longer lead times and elevated logistics expenses. Hospitals and ambulatory centers are negotiating with suppliers to establish fixed-price agreements, while specialty clinics are exploring consortium purchasing models to dilute tariff burdens. Over the medium term, this environment is catalyzing strategic partnerships between domestic assemblers and overseas component vendors, ensuring both cost containment and supply chain resilience.

Illuminating Market Structure through Detailed Segmentation

A granular understanding of market segmentation illuminates where value creation and adoption are most pronounced. When analyzed by product category, consumables such as filtration cartridges and washing kits account for a steady revenue stream, further amplified by recurring clinical demand. Within this segment, filtration cartridges remain the workhorses of blood purification, while advanced washing kits enhance membrane clearance and reduce hemolysis. In parallel, system sales-including both centrifugal autotransfusion devices and filtration autotransfusion platforms-drive high-value capital investment, reflecting hospitals’ commitment to cutting-edge intraoperative care.

Turning to applications, autotransfusion finds its strongest foothold in cardiac surgery, particularly in off-pump coronary artery bypass procedures and open heart operations where blood conservation is paramount. Trauma surgery represents another critical vertical, encompassing both combat settings where portability and rapid deployment are essential, and emergency civilian trauma centers that demand robust, user-friendly systems. Vascular interventions, in turn, leverage autotransfusion during aortic repairs and peripheral vascular grafting to minimize perioperative blood loss and transfusion dependency.

End-user segmentation underscores the diversity of deployment environments. Ambulatory surgical centers, whether freestanding or hospital-based, are adopting compact autotransfusion units to expand their procedural repertoire. Hospitals-both private and public-remain the primary purchasers of integrated systems, underpinned by substantial operating budgets and in-house expertise. Specialty clinics focused on cardiac or vascular care selectively invest in tailored consumable packs and portable devices to support niche procedures and enhance patient throughput.

Unveiling Regional Trajectories and Growth Hotspots

Regional insights reveal distinct adoption patterns and growth trajectories across the globe. In the Americas, mature healthcare systems in North America continue to lead in per-capita utilization of autotransfusion technologies, bolstered by supportive reimbursement frameworks and robust clinical guidelines. Latin American markets are gradually scaling up adoption as infrastructure investment and training initiatives gain momentum.

Across Europe, Middle East, and Africa, Western European nations set the standard for integrated autotransfusion protocols, while emerging economies in Eastern Europe and parts of the Middle East are accelerating technology transfer and local manufacturing. Regulatory harmonization efforts under regional agencies are smoothing market entry, although reimbursement volatility in certain jurisdictions poses intermittent challenges. Africa presents a nascent but promising landscape, where capacity-building and public-private partnerships are laying the groundwork for future expansion.

Asia-Pacific exhibits a dual dynamic: advanced markets such as Japan and Australia drive premium system uptake, while China and India demonstrate high growth potential fueled by large patient volumes and government initiatives to enhance surgical care. Regional supply chains are strengthening, with several domestic players entering the competitive arena and forging alliances with global technology providers.

Strategic Moves Shaping the Competitive Arena

The competitive field is shaped by a handful of dominant medical device manufacturers and a dynamic roster of emerging specialists. Established firms invest heavily in research and development to refine centrifugal speeds, optimize sensor integration, and bolster user ergonomics. These incumbents leverage extensive clinical networks to validate new protocols and accelerate adoption among key opinion leaders.

Simultaneously, nimble startups and mid-sized enterprises are carving out strategic niches through modular autotransfusion offerings, disposable-only business models, and targeted application enhancements for trauma and vascular procedures. Cross-sector collaborations between device makers and biotechnology firms are also on the rise, focusing on bioactive coatings and hemostatic additives to expand the functional scope of washing kits. Mergers and acquisitions continue to redefine market boundaries, as companies seek to consolidate consumable pipelines and unlock scale economies in global distribution.

Actionable Directives to Navigate Future Market Opportunities

To thrive in this evolving environment, industry leaders must focus on a balanced portfolio of short-term initiatives and long-term investments. Prioritizing continuous innovation in filtration efficiency and device miniaturization will address the dual demands of cost pressure and procedural versatility. Integrating digital feedback loops and predictive analytics can further differentiate product offerings by enabling data-driven optimization of intraoperative blood management.

Diversifying the supply chain by establishing manufacturing partnerships in tariff-friendly jurisdictions will mitigate geopolitical risk and stabilize pricing structures. Strengthening ties with cardiac, trauma, and vascular centers through comprehensive training programs and outcome-driven case studies will foster deeper clinical endorsement and pave the way for expanded utilization. Embracing sustainable design principles for disposable components can resonate with institutional green mandates and position companies as responsible stewards of environmental impact.

Finally, engaging proactively with regulatory bodies and payers to shape favorable reimbursement pathways is essential. By delivering robust real-world evidence on safety, efficacy, and cost savings, manufacturers can secure pathway approvals and favorable coverage decisions, thereby accelerating market penetration and reinforcing their competitive foothold.

Rigorous Methodology Underpinning Robust Market Insights

The research methodology combines a rigorous blend of primary and secondary approaches to ensure credibility and depth. Primary data collection included structured interviews with surgeons, perfusionists, hospital procurement executives, and industry veterans, providing firsthand perspectives on clinical workflows, purchasing criteria, and technology adoption hurdles. Secondary research drew on peer-reviewed journals, regulatory filings, patent databases, and financial disclosures to chart historical trends and validate technological claims.

To reconcile divergent data points, triangulation techniques were applied, cross-checking inputs from multiple sources to bolster reliability. Market intelligence tools mapped competitive positioning, while thematic analysis distilled key drivers, restraints, and emerging opportunities. This multifaceted approach provides stakeholders with a transparent audit trail of data sources and analytical frameworks, underpinning the report’s strategic recommendations with robust empirical evidence.

Synthesizing Critical Findings and Their Strategic Significance

This executive summary has traced the contours of a dynamic cardiopulmonary autotransfusion systems market, from the technological and regulatory forces reshaping its trajectory to the granular segmentation insights that reveal pockets of growth. The cumulative effect of new tariff policies underscores the importance of sourcing agility and regional partnerships in safeguarding competitiveness. Regional analysis highlights a mosaic of mature and emerging markets, each with unique drivers and barriers, while competitive intelligence spotlights the strategic maneuvers that will define leadership in the years ahead.

Collectively, these findings inform a set of strategic recommendations tailored to enhance innovation pipelines, optimize supply chains, and secure favorable reimbursement pathways. By aligning product development with clinical imperatives and regional nuances, industry stakeholders can capitalize on the expanding role of autotransfusion in surgical care, delivering improved patient outcomes and capturing long-term value.

Market Segmentation & Coverage

This research report categorizes to forecast the revenues and analyze trends in each of the following sub-segmentations:
  • Product
    • Consumables
      • Filtration Cartridges
      • Washing Kits
    • Systems
      • Centrifugal Autotransfusion
      • Filtration Autotransfusion
  • Application
    • Cardiac Surgery
      • Off Pump Coronary Artery Bypass Surgery
      • Open Heart Surgery
    • Trauma Surgery
      • Combat Trauma Surgery
      • Emergency Trauma Surgery
    • Vascular Surgery
      • Aortic Surgery
      • Peripheral Vascular Surgery
  • End User
    • Ambulatory Surgical Centers
      • Freestanding
      • Hospital Based
    • Hospitals
      • Private Hospitals
      • Public Hospitals
    • Specialty Clinics
      • Cardiac Specialty Clinics
      • Vascular Specialty Clinics
This research report categorizes to forecast the revenues and analyze trends in each of the following sub-regions:
  • Americas
    • United States
      • California
      • Texas
      • New York
      • Florida
      • Illinois
      • Pennsylvania
      • Ohio
    • Canada
    • Mexico
    • Brazil
    • Argentina
  • Europe, Middle East & Africa
    • United Kingdom
    • Germany
    • France
    • Russia
    • Italy
    • Spain
    • United Arab Emirates
    • Saudi Arabia
    • South Africa
    • Denmark
    • Netherlands
    • Qatar
    • Finland
    • Sweden
    • Nigeria
    • Egypt
    • Turkey
    • Israel
    • Norway
    • Poland
    • Switzerland
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Indonesia
    • Thailand
    • Philippines
    • Malaysia
    • Singapore
    • Vietnam
    • Taiwan
This research report categorizes to delves into recent significant developments and analyze trends in each of the following companies:
  • Haemonetics Corporation
  • Fresenius Kabi AG
  • Stryker Corporation
  • Getinge AB
  • Medtronic plc
  • LivaNova plc
  • Terumo Corporation
  • Bellco S.p.A.
  • JW Medical Systems Co., Ltd.
  • Nipro Corporation

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Cardiopulmonary Autotransfusion Systems Market, by Product
8.1. Introduction
8.2. Consumables
8.2.1. Filtration Cartridges
8.2.2. Washing Kits
8.3. Systems
8.3.1. Centrifugal Autotransfusion
8.3.2. Filtration Autotransfusion
9. Cardiopulmonary Autotransfusion Systems Market, by Application
9.1. Introduction
9.2. Cardiac Surgery
9.2.1. Off Pump Coronary Artery Bypass Surgery
9.2.2. Open Heart Surgery
9.3. Trauma Surgery
9.3.1. Combat Trauma Surgery
9.3.2. Emergency Trauma Surgery
9.4. Vascular Surgery
9.4.1. Aortic Surgery
9.4.2. Peripheral Vascular Surgery
10. Cardiopulmonary Autotransfusion Systems Market, by End User
10.1. Introduction
10.2. Ambulatory Surgical Centers
10.2.1. Freestanding
10.2.2. Hospital Based
10.3. Hospitals
10.3.1. Private Hospitals
10.3.2. Public Hospitals
10.4. Specialty Clinics
10.4.1. Cardiac Specialty Clinics
10.4.2. Vascular Specialty Clinics
11. Americas Cardiopulmonary Autotransfusion Systems Market
11.1. Introduction
11.2. United States
11.3. Canada
11.4. Mexico
11.5. Brazil
11.6. Argentina
12. Europe, Middle East & Africa Cardiopulmonary Autotransfusion Systems Market
12.1. Introduction
12.2. United Kingdom
12.3. Germany
12.4. France
12.5. Russia
12.6. Italy
12.7. Spain
12.8. United Arab Emirates
12.9. Saudi Arabia
12.10. South Africa
12.11. Denmark
12.12. Netherlands
12.13. Qatar
12.14. Finland
12.15. Sweden
12.16. Nigeria
12.17. Egypt
12.18. Turkey
12.19. Israel
12.20. Norway
12.21. Poland
12.22. Switzerland
13. Asia-Pacific Cardiopulmonary Autotransfusion Systems Market
13.1. Introduction
13.2. China
13.3. India
13.4. Japan
13.5. Australia
13.6. South Korea
13.7. Indonesia
13.8. Thailand
13.9. Philippines
13.10. Malaysia
13.11. Singapore
13.12. Vietnam
13.13. Taiwan
14. Competitive Landscape
14.1. Market Share Analysis, 2024
14.2. FPNV Positioning Matrix, 2024
14.3. Competitive Analysis
14.3.1. Haemonetics Corporation
14.3.2. Fresenius Kabi AG
14.3.3. Stryker Corporation
14.3.4. Getinge AB
14.3.5. Medtronic plc
14.3.6. LivaNova plc
14.3.7. Terumo Corporation
14.3.8. Bellco S.p.A.
14.3.9. JW Medical Systems Co., Ltd.
14.3.10. Nipro Corporation
15. ResearchAI
16. ResearchStatistics
17. ResearchContacts
18. ResearchArticles
19. Appendix
List of Figures
FIGURE 1. CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET MULTI-CURRENCY
FIGURE 2. CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET MULTI-LANGUAGE
FIGURE 3. CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY PRODUCT, 2024 VS 2030 (%)
FIGURE 8. GLOBAL CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY PRODUCT, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 10. GLOBAL CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 14. AMERICAS CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 16. UNITED STATES CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 22. CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY FILTRATION CARTRIDGES, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY WASHING KITS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY CENTRIFUGAL AUTOTRANSFUSION, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY FILTRATION AUTOTRANSFUSION, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY CARDIAC SURGERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY OFF PUMP CORONARY ARTERY BYPASS SURGERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY OPEN HEART SURGERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY CARDIAC SURGERY, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY TRAUMA SURGERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY COMBAT TRAUMA SURGERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY EMERGENCY TRAUMA SURGERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY TRAUMA SURGERY, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY VASCULAR SURGERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY AORTIC SURGERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY PERIPHERAL VASCULAR SURGERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY VASCULAR SURGERY, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY FREESTANDING, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY HOSPITAL BASED, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY CARDIAC SPECIALTY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY VASCULAR SPECIALTY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 41. AMERICAS CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 42. AMERICAS CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 43. AMERICAS CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
TABLE 44. AMERICAS CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 45. AMERICAS CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY CARDIAC SURGERY, 2018-2030 (USD MILLION)
TABLE 46. AMERICAS CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY TRAUMA SURGERY, 2018-2030 (USD MILLION)
TABLE 47. AMERICAS CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY VASCULAR SURGERY, 2018-2030 (USD MILLION)
TABLE 48. AMERICAS CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 49. AMERICAS CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 50. AMERICAS CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 51. AMERICAS CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 52. AMERICAS CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 53. UNITED STATES CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 54. UNITED STATES CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 55. UNITED STATES CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
TABLE 56. UNITED STATES CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 57. UNITED STATES CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY CARDIAC SURGERY, 2018-2030 (USD MILLION)
TABLE 58. UNITED STATES CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY TRAUMA SURGERY, 2018-2030 (USD MILLION)
TABLE 59. UNITED STATES CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY VASCULAR SURGERY, 2018-2030 (USD MILLION)
TABLE 60. UNITED STATES CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 61. UNITED STATES CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 62. UNITED STATES CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 63. UNITED STATES CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 64. UNITED STATES CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 65. CANADA CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 66. CANADA CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 67. CANADA CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
TABLE 68. CANADA CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 69. CANADA CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY CARDIAC SURGERY, 2018-2030 (USD MILLION)
TABLE 70. CANADA CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY TRAUMA SURGERY, 2018-2030 (USD MILLION)
TABLE 71. CANADA CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY VASCULAR SURGERY, 2018-2030 (USD MILLION)
TABLE 72. CANADA CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 73. CANADA CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 74. CANADA CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 75. CANADA CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 76. MEXICO CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 77. MEXICO CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 78. MEXICO CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
TABLE 79. MEXICO CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 80. MEXICO CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY CARDIAC SURGERY, 2018-2030 (USD MILLION)
TABLE 81. MEXICO CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY TRAUMA SURGERY, 2018-2030 (USD MILLION)
TABLE 82. MEXICO CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY VASCULAR SURGERY, 2018-2030 (USD MILLION)
TABLE 83. MEXICO CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 84. MEXICO CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 85. MEXICO CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 86. MEXICO CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 87. BRAZIL CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 88. BRAZIL CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 89. BRAZIL CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
TABLE 90. BRAZIL CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 91. BRAZIL CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY CARDIAC SURGERY, 2018-2030 (USD MILLION)
TABLE 92. BRAZIL CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY TRAUMA SURGERY, 2018-2030 (USD MILLION)
TABLE 93. BRAZIL CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY VASCULAR SURGERY, 2018-2030 (USD MILLION)
TABLE 94. BRAZIL CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 95. BRAZIL CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 96. BRAZIL CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 97. BRAZIL CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 98. ARGENTINA CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 99. ARGENTINA CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 100. ARGENTINA CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
TABLE 101. ARGENTINA CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 102. ARGENTINA CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY CARDIAC SURGERY, 2018-2030 (USD MILLION)
TABLE 103. ARGENTINA CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY TRAUMA SURGERY, 2018-2030 (USD MILLION)
TABLE 104. ARGENTINA CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY VASCULAR SURGERY, 2018-2030 (USD MILLION)
TABLE 105. ARGENTINA CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 106. ARGENTINA CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 107. ARGENTINA CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 108. ARGENTINA CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 109. EUROPE, MIDDLE EAST & AFRICA CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 110. EUROPE, MIDDLE EAST & AFRICA CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 111. EUROPE, MIDDLE EAST & AFRICA CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
TABLE 112. EUROPE, MIDDLE EAST & AFRICA CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 113. EUROPE, MIDDLE EAST & AFRICA CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY CARDIAC SURGERY, 2018-2030 (USD MILLION)
TABLE 114. EUROPE, MIDDLE EAST & AFRICA CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY TRAUMA SURGERY, 2018-2030 (USD MILLION)
TABLE 115. EUROPE, MIDDLE EAST & AFRICA CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY VASCULAR SURGERY, 2018-2030 (USD MILLION)
TABLE 116. EUROPE, MIDDLE EAST & AFRICA CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 117. EUROPE, MIDDLE EAST & AFRICA CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 118. EUROPE, MIDDLE EAST & AFRICA CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 119. EUROPE, MIDDLE EAST & AFRICA CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 120. EUROPE, MIDDLE EAST & AFRICA CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 121. UNITED KINGDOM CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 122. UNITED KINGDOM CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 123. UNITED KINGDOM CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
TABLE 124. UNITED KINGDOM CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 125. UNITED KINGDOM CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY CARDIAC SURGERY, 2018-2030 (USD MILLION)
TABLE 126. UNITED KINGDOM CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY TRAUMA SURGERY, 2018-2030 (USD MILLION)
TABLE 127. UNITED KINGDOM CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY VASCULAR SURGERY, 2018-2030 (USD MILLION)
TABLE 128. UNITED KINGDOM CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 129. UNITED KINGDOM CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 130. UNITED KINGDOM CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 131. UNITED KINGDOM CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 132. GERMANY CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 133. GERMANY CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 134. GERMANY CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
TABLE 135. GERMANY CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 136. GERMANY CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY CARDIAC SURGERY, 2018-2030 (USD MILLION)
TABLE 137. GERMANY CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY TRAUMA SURGERY, 2018-2030 (USD MILLION)
TABLE 138. GERMANY CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY VASCULAR SURGERY, 2018-2030 (USD MILLION)
TABLE 139. GERMANY CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 140. GERMANY CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 141. GERMANY CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 142. GERMANY CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 143. FRANCE CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 144. FRANCE CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 145. FRANCE CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
TABLE 146. FRANCE CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 147. FRANCE CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY CARDIAC SURGERY, 2018-2030 (USD MILLION)
TABLE 148. FRANCE CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY TRAUMA SURGERY, 2018-2030 (USD MILLION)
TABLE 149. FRANCE CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY VASCULAR SURGERY, 2018-2030 (USD MILLION)
TABLE 150. FRANCE CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 151. FRANCE CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 152. FRANCE CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 153. FRANCE CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 154. RUSSIA CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 155. RUSSIA CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 156. RUSSIA CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
TABLE 157. RUSSIA CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 158. RUSSIA CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY CARDIAC SURGERY, 2018-2030 (USD MILLION)
TABLE 159. RUSSIA CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY TRAUMA SURGERY, 2018-2030 (USD MILLION)
TABLE 160. RUSSIA CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY VASCULAR SURGERY, 2018-2030 (USD MILLION)
TABLE 161. RUSSIA CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 162. RUSSIA CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 163. RUSSIA CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 164. RUSSIA CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 165. ITALY CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 166. ITALY CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 167. ITALY CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
TABLE 168. ITALY CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 169. ITALY CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY CARDIAC SURGERY, 2018-2030 (USD MILLION)
TABLE 170. ITALY CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY TRAUMA SURGERY, 2018-2030 (USD MILLION)
TABLE 171. ITALY CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY VASCULAR SURGERY, 2018-2030 (USD MILLION)
TABLE 172. ITALY CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 173. ITALY CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 174. ITALY CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 175. ITALY CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 176. SPAIN CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 177. SPAIN CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 178. SPAIN CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
TABLE 179. SPAIN CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 180. SPAIN CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY CARDIAC SURGERY, 2018-2030 (USD MILLION)
TABLE 181. SPAIN CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY TRAUMA SURGERY, 2018-2030 (USD MILLION)
TABLE 182. SPAIN CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY VASCULAR SURGERY, 2018-2030 (USD MILLION)
TABLE 183. SPAIN CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 184. SPAIN CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 185. SPAIN CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 186. SPAIN CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 187. UNITED ARAB EMIRATES CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 188. UNITED ARAB EMIRATES CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 189. UNITED ARAB EMIRATES CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
TABLE 190. UNITED ARAB EMIRATES CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 191. UNITED ARAB EMIRATES CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY CARDIAC SURGERY, 2018-2030 (USD MILLION)
TABLE 192. UNITED ARAB EMIRATES CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY TRAUMA SURGERY, 2018-2030 (USD MILLION)
TABLE 193. UNITED ARAB EMIRATES CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY VASCULAR SURGERY, 2018-2030 (USD MILLION)
TABLE 194. UNITED ARAB EMIRATES CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 195. UNITED ARAB EMIRATES CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 196. UNITED ARAB EMIRATES CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 197. UNITED ARAB EMIRATES CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 198. SAUDI ARABIA CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 199. SAUDI ARABIA CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 200. SAUDI ARABIA CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
TABLE 201. SAUDI ARABIA CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 202. SAUDI ARABIA CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY CARDIAC SURGERY, 2018-2030 (USD MILLION)
TABLE 203. SAUDI ARABIA CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY TRAUMA SURGERY, 2018-2030 (USD MILLION)
TABLE 204. SAUDI ARABIA CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY VASCULAR SURGERY, 2018-2030 (USD MILLION)
TABLE 205. SAUDI ARABIA CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 206. SAUDI ARABIA CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 207. SAUDI ARABIA CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 208. SAUDI ARABIA CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 209. SOUTH AFRICA CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 210. SOUTH AFRICA CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 211. SOUTH AFRICA CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
TABLE 212. SOUTH AFRICA CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 213. SOUTH AFRICA CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY CARDIAC SURGERY, 2018-2030 (USD MILLION)
TABLE 214. SOUTH AFRICA CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY TRAUMA SURGERY, 2018-2030 (USD MILLION)
TABLE 215. SOUTH AFRICA CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY VASCULAR SURGERY, 2018-2030 (USD MILLION)
TABLE 216. SOUTH AFRICA CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 217. SOUTH AFRICA CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 218. SOUTH AFRICA CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 219. SOUTH AFRICA CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 220. DENMARK CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 221. DENMARK CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 222. DENMARK CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
TABLE 223. DENMARK CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 224. DENMARK CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY CARDIAC SURGERY, 2018-2030 (USD MILLION)
TABLE 225. DENMARK CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY TRAUMA SURGERY, 2018-2030 (USD MILLION)
TABLE 226. DENMARK CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY VASCULAR SURGERY, 2018-2030 (USD MILLION)
TABLE 227. DENMARK CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 228. DENMARK CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 229. DENMARK CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 230. DENMARK CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 231. NETHERLANDS CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 232. NETHERLANDS CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 233. NETHERLANDS CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
TABLE 234. NETHERLANDS CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 235. NETHERLANDS CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY CARDIAC SURGERY, 2018-2030 (USD MILLION)
TABLE 236. NETHERLANDS CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY TRAUMA SURGERY, 2018-2030 (USD MILLION)
TABLE 237. NETHERLANDS CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY VASCULAR SURGERY, 2018-2030 (USD MILLION)
TABLE 238. NETHERLANDS CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 239. NETHERLANDS CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 240. NETHERLANDS CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 241. NETHERLANDS CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 242. QATAR CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 243. QATAR CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 244. QATAR CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
TABLE 245. QATAR CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 246. QATAR CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY CARDIAC SURGERY, 2018-2030 (USD MILLION)
TABLE 247. QATAR CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY TRAUMA SURGERY, 2018-2030 (USD MILLION)
TABLE 248. QATAR CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY VASCULAR SURGERY, 2018-2030 (USD MILLION)
TABLE 249. QATAR CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 250. QATAR CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 251. QATAR CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 252. QATAR CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 253. FINLAND CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 254. FINLAND CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 255. FINLAND CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
TABLE 256. FINLAND CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 257. FINLAND CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY CARDIAC SURGERY, 2018-2030 (USD MILLION)
TABLE 258. FINLAND CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY TRAUMA SURGERY, 2018-2030 (USD MILLION)
TABLE 259. FINLAND CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY VASCULAR SURGERY, 2018-2030 (USD MILLION)
TABLE 260. FINLAND CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 261. FINLAND CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 262. FINLAND CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 263. FINLAND CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 264. SWEDEN CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 265. SWEDEN CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 266. SWEDEN CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
TABLE 267. SWEDEN CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 268. SWEDEN CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY CARDIAC SURGERY, 2018-2030 (USD MILLION)
TABLE 269. SWEDEN CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY TRAUMA SURGERY, 2018-2030 (USD MILLION)
TABLE 270. SWEDEN CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY VASCULAR SURGERY, 2018-2030 (USD MILLION)
TABLE 271. SWEDEN CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 272. SWEDEN CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 273. SWEDEN CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 274. SWEDEN CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 275. NIGERIA CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 276. NIGERIA CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 277. NIGERIA CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
TABLE 278. NIGERIA CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 279. NIGERIA CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY CARDIAC SURGERY, 2018-2030 (USD MILLION)
TABLE 280. NIGERIA CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY TRAUMA SURGERY, 2018-2030 (USD MILLION)
TABLE 281. NIGERIA CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY VASCULAR SURGERY, 2018-2030 (USD MILLION)
TABLE 282. NIGERIA CARDIOPULMONARY AUTOTRA

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Cardiopulmonary Autotransfusion Systems market report include:
  • Haemonetics Corporation
  • Fresenius Kabi AG
  • Stryker Corporation
  • Getinge AB
  • Medtronic plc
  • LivaNova plc
  • Terumo Corporation
  • Bellco S.p.A.
  • JW Medical Systems Co., Ltd.
  • Nipro Corporation

Table Information

Report AttributeDetails
No. of Pages188
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 599 Million
Forecasted Market Value ( USD ) by 2030 $ 689.52 Million
Compound Annual Growth Rate2.8%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Cardiopulmonary Autotransfusion Systems - Global Strategic Business Report - Product Image

Cardiopulmonary Autotransfusion Systems - Global Strategic Business Report

  • Report
  • 179 Pages
  • Global
From
Autotransfusion System Market by Product Type, Application, End User, Technology, Patient Type - Global Forecast to 2030 - Product Image

Autotransfusion System Market by Product Type, Application, End User, Technology, Patient Type - Global Forecast to 2030

  • Report
  • 191 Pages
  • Global
From
Autotransfusion Devices Market Size, Share & Trends Analysis Report By Type (Autotransfusion Systems, Consumables& Accessories), By Application, By End Use (Hospitals & Clinics), By Region And Segment Forecasts, 2024 - 2030 - Product Image

Autotransfusion Devices Market Size, Share & Trends Analysis Report By Type (Autotransfusion Systems, Consumables& Accessories), By Application, By End Use (Hospitals & Clinics), By Region And Segment Forecasts, 2024 - 2030

  • Report
  • 120 Pages
  • Global
From
Autotransfusion System Market Report: Trends, Forecast and Competitive Analysis to 2030 - Product Image

Autotransfusion System Market Report: Trends, Forecast and Competitive Analysis to 2030

  • Report
  • 150 Pages
  • Global
From
Autotransfusion Systems - Global Strategic Business Report - Product Image

Autotransfusion Systems - Global Strategic Business Report

  • Report
  • 93 Pages
  • Global
From

About the Cardiopulmonary Autotransfusion System Market

The Cardiopulmonary Autotransfusion System (CPAT) is a cardiovascular device used to collect, store, and reinfuse a patient's own blood during cardiac surgery. It is designed to reduce the need for donor blood transfusions, which can carry risks such as infection and immunological reactions. CPAT systems typically consist of a blood collection device, a blood storage device, and a blood reinfusion device. The collection device is used to collect the patient's blood during surgery, while the storage device is used to store the blood until it is needed. The reinfusion device is used to reinfuse the patient's blood back into the patient's body. CPAT systems are used in a variety of cardiac surgeries, including coronary artery bypass grafting, valve replacement, and heart transplantation. They are also used in other types of surgeries, such as orthopedic and plastic surgery. CPAT systems are becoming increasingly popular due to their ability to reduce the need for donor blood transfusions and the associated risks. Some companies in the CPAT market include Haemonetics Corporation, Fresenius Medical Care, and Terumo Corporation. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.